Washington, D.C. – U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced $727,425 in federal dollars to help advance medical research and treatment at New York Medical College in Valhalla. These funds from the U.S. Department of Health and Human Services will help move forward on critical research and treatment to help improve the lives of all New Yorkers, and are part of the American Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped pass earlier this year.
“Federal funding for medical research and training is needed now more than ever,” said Schumer. “In these difficult economic times, it is critical that we continue to invest in cutting-edge medical research to push the boundaries of medicine and promote long-term economic growth. I will continue to fight for federal funds that will advance the New York Medical College as a world-class research institution.”
“It is critical that we invest in the life-saving research at our world class medical facilities in Westchester County,” said Senator Gillibrand. “Federal funding for this cutting edge research will advance research and treatment while promoting economic growth for New York. I will continue to work with Senator Schumer to make sure New York gets its fair share of federal dollars.”
New York Medical College will receive $329,925 for research to improve treatment to address thyroid size in women suffering from goiter and cancer. New York Medical College will also receive $397,500 to research cardiac muscle regeneration in embryos to help develop treatments for the adult heart diseases.
Senators Schumer and Gillibrand are strong supporters of President Obama’s economic plan. The investment will help create or save more than 200,000 jobs in New York, while laying the foundation of future economic growth with critical investments in health care technology and research, education, infrastructure and renewable energy.